Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome

Abstract

There are limited real-world data on prevalence and predictors of dual antiplatelet therapy (DAPT) prolongation beyond one year after acute coronary syndrome (ACS). We have explored such issue in the START ANTIPLATELET Registry, which is a prospective, observational, multicenter, Italian registry performed in seven Italian cardiology institutions including… (More)
DOI: 10.1371/journal.pone.0186961

Topics

3 Figures and Tables

Cite this paper

@inproceedings{Patti2017PrevalenceAP, title={Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome}, author={Giuseppe Patti and Ilaria Cavallari and Emilia Antonucci and Paolo Calabr{\`o} and Plinio Cirillo and Paolo Gresele and Gualtiero Palareti and Vittorio Pengo and Pasquale Pignatelli and Elisabetta Ricottini and Rossella Marcucci}, booktitle={PloS one}, year={2017} }